Related Experiment Video
Updated: May 12, 2026
10:50
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
7.7K
Primary CNS Vasculitis - A Focussed Review on Treatment
Praveen Kesav1, Divya Manesh Raj2, Rula A Hajj-Ali3
1Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Vascular Health and Risk Management
|October 29, 2024
Summary
Primary central nervous system vasculitis (PCNSV) is a rare condition. This review outlines current treatment approaches and proposes a management strategy for PCNSV.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Primary central nervous system vasculitis (PCNSV) is a rare and complex condition.
- Despite advancements, PCNSV presents significant diagnostic and therapeutic challenges.
- Optimal management strategies for PCNSV remain incompletely defined.
Purpose of the Study:
- To provide a detailed outline of current treatment approaches for PCNSV.
- To critically appraise existing cohort data on PCNSV treatment outcomes.
- To propose a structured treatment approach for PCNSV.
Main Methods:
- Exhaustive review of available cohort series of PCNSV.
- Critical appraisal of study definitions, treatment strategies, and outcome predictors.
- Synthesis of evidence to formulate a proposed treatment algorithm.
Main Results:
- Analysis of cohort data reveals variability in PCNSV definitions and treatment protocols.
- Identification of key predictors for treatment response in PCNSV patients.
- Current treatments show variable efficacy, highlighting the need for standardized approaches.
Conclusions:
- PCNSV diagnosis and management require a multidisciplinary approach.
- Standardized diagnostic criteria and evidence-based treatment protocols are crucial.
- The proposed treatment strategy aims to optimize outcomes for PCNSV patients.
Related Concept Videos
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...